|
EU: Crunch Time for Counterfeit Medicines
Tensions are rising in Europe’s pharmaceutical sector as crunch-time approaches for the legislation to combat counterfeits. By this time next year, the European Commission is due to have decided on the mechanisms required to put into effect the European Union’s hugely complex new rules to keep falsified medicines out of the legal supply chain ...Read more |
Read the Latest Pharm Exec Global Digest
In the new June issue: Adherence Focus — the latest policy and technological issues around around the world; Japan: the country that cost containment forgot: and commercial model design as a growth enabler ... Read more |
2013: Year of Mobile Health
Mobile health is getting some serious attention — from an unusual but inspiring new Apple ad to an ambitious new study setting out to spotlight the best examples of mHealth by the leading Pharma companies. Peter Houston reports ... Read more
|
Helping Patients Lead the Way in the New NHS
NHS England is currently undergoing profound changes to introduce a new culture where clinicians and patients are the new stars, where competition is mandatory, where everything rests on patient outcomes and where collaboration and innovation are being encouraged at the highest levels of command. Jacky Law investigates how pharma companies can get on board with the changes ... Read more
|
When Management Gurus Get it Wrong
How can eminent management gurus whose strategy advice proves so valuable across business in general sometimes get it so wrong on pharma? John Ansell provides a few cautionary tales about stumbles involving some of the most celebrated experts ... Read more
|
China Report
China is the third largest pharmaceutical market in the world and will become the second largest ahead of Japan by 2015. Everything you need to know to do business in the country; key economic sector data and exclusive interviews from regional leaders ... Read more
|
|
